中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2014年
2期
272-274
,共3页
范钰%徐娟%满昌峰%彭辉勇%祁卫东%蒋鹏程
範鈺%徐娟%滿昌峰%彭輝勇%祁衛東%蔣鵬程
범옥%서연%만창봉%팽휘용%기위동%장붕정
大肠肿瘤%Cripto-3
大腸腫瘤%Cripto-3
대장종류%Cripto-3
Colon carcinoma%Cripto-3
目的 探讨假基因Cripto-3(Cr-3)在人大肠癌组织中的临床意义.方法 收集人大肠癌和正常大肠黏膜组织,采用荧光实时定量聚合酶链反应法检测组织中mRNA水平,分析其表达与患者性别、肿瘤发生部位、分化程度、浆膜侵袭、淋巴结转移及Duke's分期的相关性,并作统计学处理.结果 在大肠癌组织中Cr-3阳性率为75.0% (27/36),在正常大肠黏膜组织中,Cr-3阳性率为0% (0/36,P<0.05).进一步发现Cr-3阳性率分别与浆膜层侵袭、淋巴结转移和Duke's分期有关(P<0.05);而与患者性别、肿瘤发生部位和分化程度无关(P>0.05).结论 假基因Cr-3可能是大肠癌基因诊断和治疗中重要靶点之一.
目的 探討假基因Cripto-3(Cr-3)在人大腸癌組織中的臨床意義.方法 收集人大腸癌和正常大腸黏膜組織,採用熒光實時定量聚閤酶鏈反應法檢測組織中mRNA水平,分析其錶達與患者性彆、腫瘤髮生部位、分化程度、漿膜侵襲、淋巴結轉移及Duke's分期的相關性,併作統計學處理.結果 在大腸癌組織中Cr-3暘性率為75.0% (27/36),在正常大腸黏膜組織中,Cr-3暘性率為0% (0/36,P<0.05).進一步髮現Cr-3暘性率分彆與漿膜層侵襲、淋巴結轉移和Duke's分期有關(P<0.05);而與患者性彆、腫瘤髮生部位和分化程度無關(P>0.05).結論 假基因Cr-3可能是大腸癌基因診斷和治療中重要靶點之一.
목적 탐토가기인Cripto-3(Cr-3)재인대장암조직중적림상의의.방법 수집인대장암화정상대장점막조직,채용형광실시정량취합매련반응법검측조직중mRNA수평,분석기표체여환자성별、종류발생부위、분화정도、장막침습、림파결전이급Duke's분기적상관성,병작통계학처리.결과 재대장암조직중Cr-3양성솔위75.0% (27/36),재정상대장점막조직중,Cr-3양성솔위0% (0/36,P<0.05).진일보발현Cr-3양성솔분별여장막층침습、림파결전이화Duke's분기유관(P<0.05);이여환자성별、종류발생부위화분화정도무관(P>0.05).결론 가기인Cr-3가능시대장암기인진단화치료중중요파점지일.
Objective To study the clinical significance of pseudogene Cripto-3 (Cr-3) mRNA in human colorectal carcinoma.Methods After human colorectal normal tissues and colorectal tumoral tissues were collected,the mRNA levels of these tissues were determined by real time polymerase chain reaction.Furthermore,the gender,tumor location,and differentiation degree,and serosal invasion,and lymph node metastasis,and Duke's clinical stage were analyzed.Results The positive rates of Cr-3 in colorectal carcinoma was 75% (27/36),however,in normal colorectal mucosa,the positive rate of Cr-3 was 0%(0/36) (P < 0.05).The positive rates of Cr-3 was closely correlated to the cancer cell invasion,and lymph node metastasis and Duke' s stage (P < 0.05),but the positive rates of Cr-3 was not correlated to gender,tumor location and differentiation degree(P > 0.05).Conclusion Cr-3 gene might be one of the important target of gene diagnosis and gene therapy of colorectal cancer.